Supplements · Sweeteners · Diets
allulose causes osmotic diarrhea
In plain terms: Can the sweetener allulose give you diarrhea?
Part of: 🧪 allulose
Probably yes — but only at large doses; the small amounts used to blunt blood sugar are well below that threshold.
📅 Last reviewed: 2026-07-15 ⓘ
Evidence ladder
How far up the ladder this claim has climbed. A high consensus on a low rung means "consistent so far," not "proven in people."
Top evidence so far: Human trials (RCT / n-of-1)
How the studies fall
What the evidence shows
Allulose causes dose-dependent osmotic diarrhea above ~0.4 g/kg single dose (~28 g for a 70 kg adult); effective glycemic doses (5-10 g) are comfortably below the threshold. Well-tolerated at food-relevant doses.
The evidence (12)
| Source | Grade | Stance | Quality | Finding |
|---|---|---|---|---|
| Ndjite GM et al 2024 · bioRxiv (Cold Spring Harbor Laboratory) | in-vitro | tested-null | moderate | bioRxiv preprint (duplicate of pmid:40595444): AlsE enzyme distribution limited to 15.8% of human gut metagenomic samples, suggesting minimal gut microbial capacity to ferment D-allulose. |
| Han Y, et al. 2018 · Nutrients | RCT | tested-null | low | 121 Korean overweight adults tolerated 4g and 7g/dose d-allulose twice daily for 12wk without significant GI/diarrhea events at these moderate doses |
| Nishii N et al 2016 · study_type: animal | animal | supports | low | Single acute oral doses of D-allulose in dogs: 1 g/kg tolerated; at 4 g/kg, 5/6 dogs showed transient diarrhea and 1 vomited. Blood glucose dipped slightly without an insulin rise. |
| Minabou Ndjite G et al 2025 · study_type: mechanism | in-vitro | tested-null | moderate | AlsE enzyme needed to metabolize D-allulose is present in only 15.8% of human gut metagenomes and in a limited (116/85,202) set of bacterial species, suggesting minimal microbial fermentation of allulose in the colon. |
| Risso 2024 2024 · Food Funct | RCT | supports | moderate | [FT-verified] Risso 2024 RCT children 2.5/4.3g well-tolerated only 1 loose stool; confirms threshold |
| Iida 2010 2010 · Metabolism | observational | supports | moderate | [FT-verified] Iida 2010 psicose ~70% renally excreted poorly fermented; osmotic-laxation basis at high dose |
| Braunstein CR et al] # corrected 2026-08-17 from PubMed; was [(Sievenpiper group) 2020 · Clin Nutr | meta-analysis | mixed | high | MA of fructose epimers <=30g/meal; benefits at low doses, with osmotic/GI symptoms emerging at higher allulose intakes flagged for tolerance |
| Osborn 2026 2026 · Am J Clin Nutr | meta-analysis | mixed | high | SR/MA of allulose & tagatose trials; glycemic benefit at catalytic doses, with GI/laxative effects the main dose-limiting tolerability concern |
| Chen HP et al 2025 · Nutrients | observational | mixed | low | Narrative review of low-calorie sweeteners' metabolic/GI/cardiovascular effects broadly; notes LCS can affect gut microbiota and that effects are context- and agent-dependent, without allulose-specific dose-diarrhea data. |
| Fukunaga K et al] # corrected 2026-08-17 from PubMed; was [(T2D CGM crossover) 2023 · (RCT) | RCT | tested-null | low | A diabetic diet with 8.5 g D-allulose improved glucose without a diarrhea signal, indicating moderate doses are tolerated while high doses provoke symptoms. |
| Han Y et al] # corrected 2026-08-17 from PubMed; was [(tolerance trial) 2018 · Nutrients | observational | supports | moderate | GI-tolerance trial severe diarrhea at 0.5 g/kg single dose; tolerated <=0.4 g/kg max daily 0.9 |
| Hayashi 2010 · Biosci Biotechnol Biochem | RCT | tested-null | moderate | Single 5g D-psicose with meal in 26 adults incl borderline diabetics suppressed glucose with no diarrhea/GI adverse events at low dose |
Disagree, or know a study we missed?
We grade by evidence, not opinions. The way to weigh in is to point us to a study we haven't cited (check the evidence table above first), or to flag a problem with one we have. Every submission is reviewed; if it holds up, the grade updates and shows in Science Changes Its Mind.
Opens a short form. You'll sign in with Google so submissions are tied to a real account — we don't display your identity, and we only accept a link we can verify (PubMed, DOI, ClinicalTrials.gov).
Educational only, not medical advice. Grades and scores reflect published evidence weighted by study design and quality; see the methodology.